CSIMarket
 
Pro dex Inc   (PDEX)
Other Ticker:  
 
 
Price: $17.2000 $0.05 0.292%
Day's High: $17.55 Week Perf: -0.75 %
Day's Low: $ 17.01 30 Day Perf: -6.19 %
Volume (M): 9 52 Wk High: $ 22.99
Volume (M$): $ 155 52 Wk Avg: $17.53
Open: $17.05 52 Wk Low: $14.51



 Market Capitalization (Millions $) 62
 Shares Outstanding (Millions) 4
 Employees -
 Revenues (TTM) (Millions $) 48
 Net Income (TTM) (Millions $) 5
 Cash Flow (TTM) (Millions $) 1
 Capital Exp. (TTM) (Millions $) 1

Pro Dex Inc
Pro dex Inc is a manufacturing company that specializes in the design, development, and production of precision motion control and assembly systems, as well as metal components and products for various industries. They offer a range of services including engineering, prototyping, manufacturing, and assembly. Pro dex Inc has a strong reputation for delivering high-quality and innovative solutions to their clients. They have a skilled team of engineers and technicians who are experienced in creating custom-made products to meet specific requirements.


   Company Address: 2361 McGaw Avenue Irvine 92614 CA
   Company Phone Number: 769-3200   Stock Exchange / Ticker: NASDAQ PDEX
   


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Pro Dex Inc

Pro Dex Inc Delivers Impressive Performance in Second Quarter of 2024 with Excellent Results2. Concerns Arise as Pro Dex Inc Achieves Strong Revenue Growth, but experiences a Decline in Earnings per Share3. Pro Dex Inc Outshines Competitors in Medical Equipment & Supplies Sector with Remarkable Second Quarter Performance.

Pro Dex Inc, a medical equipment and supplies company, recently reported its financial results for the second quarter of 2024. While the company saw a significant improvement in revenue, with a growth of 11.576% to $12.59 million compared to the same period last year, the earnings per share (EPS) declined by -41.67% to $0.14 per share. This reduction in EPS is a cause for concern, despite the increase in revenue.
In comparison to its sector contemporaries, Pro Dex Inc's revenue growth in the second quarter of 2024 stands out positively, as the overall growth in the Medical Equipment & Supplies sector was only 3.13% during the same period. This indicates that the company is performing well in terms of revenue generation within its sector.

Pro Dex Inc

Pro Dex Inc's Astounding Performance: A Remarkable Journey from July to September 2023


As I analyze the financial results of Pro Dex Inc for the first quarter of 2024, I am met with a mix of positives and challenges. In this article, I aim to dive deep into the numbers and provide an insight into the company's performance.
Starting with the bottom line, Pro Dex Inc faced a loss per stock of $-0.17 per share in the first quarter of 2024, a significant decline compared to $0.29 per share reported a year ago. Even more contrasting is the fact that it plummeted from break-even in the preceding quarter. This decline in profitability raises concerns about the company's ability to generate consistent returns for its shareholders.

Pro Dex Inc

Revised Headline: Pro Dex Inc Faces Challenging Quarter Amidst Industry Downturn

Pro Dex Inc, a medical equipment and supplies company, has reported its fiscal fourth-quarter results for 2023. The company experienced a zero gain of $0.00 per share in the quarter, compared to $0.19 per share the previous year and $0.36 per share in the previous reporting period. This decline in earnings is in line with the overall slump in the Medical Equipment & Supplies industry, which recorded a revenue rise.
The company's revenue also declined in the fourth quarter, dropping by 15.664% to $10.64 million from $12.62 million in the same period the previous year. Sequentially, revenue fell by 18.656% from $13.08 million. This decrease can be attributed to the challenging market conditions and slower demand in the industry.

Pro Dex Inc

Pro Dex Inc Soars with Impressive 41.166% Revenue Surge in Q1 2023

Investors in the stock market should approach Pro Dex Inc with caution, as the company's return on asset (ROA) in its third quarter of 2023 was below its average ROA. The 9.58% ROA is an improvement from the previous quarter, but 31 other healthcare companies had a higher ROA. While the company's overall ranking for ROA has improved, it is still lower than expectedPro Dex Inc's EPS more than doubled in the first quarter of 2023, and its revenue grew by 41.166%. The company also saw an increase in net income and profit margins. However, its operating earnings showed only a 102.25% improvement.
Investors should keep an eye on the company's next financial results report, expected in September 2023. While there are some positive signs for Pro Dex Inc, the company's below-average ROA requires careful consideration before investing in it.
As always, investors should do their own research and consult with financial experts before making any investment decisions. The stock market can be unpredictable, and a well-informed investment strategy can mitigate risk while seeking positive returns.






 

Pro Dex Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com